Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
Colorcon
Mallinckrodt
AstraZeneca
Cerilliant
Baxter
Farmers Insurance
Accenture
Express Scripts

Generated: January 16, 2018

DrugPatentWatch Database Preview

Octreotide acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for octreotide acetate and what is the scope of octreotide acetate freedom to operate?

Octreotide acetate
is the generic ingredient in five branded drugs marketed by Fresenius Kabi Usa, Sagent Pharms, Sun Pharm Inds, Teva Pharms Usa, West-ward Pharms Int, Wockhardt Usa, Mylan Institutional, and Novartis, and is included in eighteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Octreotide acetate has thirty-seven patent family members in twenty-five countries.

There are eighteen drug master file entries for octreotide acetate. Nine suppliers are listed for this compound.
Pharmacology for octreotide acetate
Medical Subject Heading (MeSH) Categories for octreotide acetate

US Patents and Regulatory Information for octreotide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 077329-002 Mar 4, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 075957-002 Oct 3, 2005 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 077330-001 Mar 4, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt Usa OCTREOTIDE ACETATE PRESERVATIVE FREE octreotide acetate INJECTABLE;INJECTION 090985-003 May 11, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 076313-001 Mar 28, 2005 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 076330-001 Apr 8, 2005 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sagent Pharms OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 091041-001 Nov 12, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis SANDOSTATIN octreotide acetate INJECTABLE;INJECTION 019667-001 Oct 21, 1988 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 076313-003 Mar 28, 2005 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 077329-003 Mar 4, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for octreotide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis SANDOSTATIN octreotide acetate INJECTABLE;INJECTION 019667-002 Oct 21, 1988 ➤ Subscribe ➤ Subscribe
Novartis SANDOSTATIN octreotide acetate INJECTABLE;INJECTION 019667-005 Jun 12, 1991 ➤ Subscribe ➤ Subscribe
Novartis SANDOSTATIN LAR octreotide acetate INJECTABLE;INJECTION 021008-001 Nov 25, 1998 ➤ Subscribe ➤ Subscribe
Novartis SANDOSTATIN octreotide acetate INJECTABLE;INJECTION 019667-001 Oct 21, 1988 ➤ Subscribe ➤ Subscribe
Novartis SANDOSTATIN octreotide acetate INJECTABLE;INJECTION 019667-003 Oct 21, 1988 ➤ Subscribe ➤ Subscribe
Novartis SANDOSTATIN LAR octreotide acetate INJECTABLE;INJECTION 021008-003 Nov 25, 1998 ➤ Subscribe ➤ Subscribe
Novartis SANDOSTATIN LAR octreotide acetate INJECTABLE;INJECTION 021008-001 Nov 25, 1998 ➤ Subscribe ➤ Subscribe
Novartis SANDOSTATIN LAR octreotide acetate INJECTABLE;INJECTION 021008-003 Nov 25, 1998 ➤ Subscribe ➤ Subscribe
Novartis SANDOSTATIN LAR octreotide acetate INJECTABLE;INJECTION 021008-003 Nov 25, 1998 ➤ Subscribe ➤ Subscribe
Novartis SANDOSTATIN LAR octreotide acetate INJECTABLE;INJECTION 021008-001 Nov 25, 1998 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for octreotide acetate

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Chubb
US Department of Justice
Novartis
Express Scripts
Argus Health
Healthtrust
Johnson and Johnson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot